Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022

View ORCID ProfileJoshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
doi: https://doi.org/10.1101/2022.09.20.22280173
Joshua J. Anzinger
aThe University of the West Indies, Kingston, Jamaica
bThe Global Virus Network Jamaica Affiliate, Kingston, Jamaica
cAbbott Pandemic Defense Coalition, The University of the West Indies, Mona, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua J. Anzinger
  • For correspondence: joshua.anzinger{at}uwimona.edu.jm
Suzette M. Cameron-McDermott
aThe University of the West Indies, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yakima Z.R. Phillips
aThe University of the West Indies, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leshawn Mendoza
dMinistry of Health and Wellness, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Anderson
eAbbott Laboratories, Infectious Disease Research, Abbott Park, Illinois, United States of America
fAbbott Pandemic Defense Coalition, Abbott Park, Illinois, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Cloherty
eAbbott Laboratories, Infectious Disease Research, Abbott Park, Illinois, United States of America
fAbbott Pandemic Defense Coalition, Abbott Park, Illinois, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Strachan-Johnson
dMinistry of Health and Wellness, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Lindo
aThe University of the West Indies, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Peter Figueroa
aThe University of the West Indies, Kingston, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
PreviousNext
Posted September 21, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
Joshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
medRxiv 2022.09.20.22280173; doi: https://doi.org/10.1101/2022.09.20.22280173
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
Joshua J. Anzinger, Suzette M. Cameron-McDermott, Yakima Z.R. Phillips, Leshawn Mendoza, Mark Anderson, Gavin Cloherty, Susan Strachan-Johnson, John F. Lindo, J. Peter Figueroa
medRxiv 2022.09.20.22280173; doi: https://doi.org/10.1101/2022.09.20.22280173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)